Clinic
Hendrick Medical Center
Hendrick Medical Center was paid $22.84M by Medicaid between Mar 2019 and Dec 2024, across 172 billing codes. Its largest line is 99284, emergency room visit (serious) — 59% of everything it billed.
33Billing provider infoHENDRICK MEDICAL CENTER
ABILENE, TX 79601
ABILENE, TX 79601
33aNPI1528064649assigned 06/23/2005
33bProvider typeCardiac Rehabilitation Clinic/Center
28Total paid$22.84M
24GClaims357,432
24DCodes billed172
24AFirst – last monthMar 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 491 | $31K | |
| 2020 | 5,608 | $500K | |
| 2021 | 97,059 | $4.94M | |
| 2022 | 100,509 | $6.99M | |
| 2023 | 97,893 | $7.00M | |
| 2024incomplete | 55,872 | $3.38M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 59% | 23,314 | 22,174 | $13.50M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 32,520 | 31,592 | $3.80M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 3,857 | 3,574 | $1.66M |
| 41899 | Unlisted procedure, dentoalveolar structures | 5.7% | 1,288 | 1,247 | $1.30M |
| 87428 | 1.7% | 16,484 | 15,977 | $378K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.6% | 2,108 | 536 | $354K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.1% | 2,539 | 2,451 | $255K |
| 59025 | Fetal non-stress test | <1% | 1,900 | 1,196 | $201K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,910 | 32,951 | $135K |
| 80053 | Comprehensive metabolic panel | <1% | 29,916 | 27,033 | $112K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,030 | 1,754 | $89K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,632 | 6,132 | $82K |
160 more codes
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 763 | $77K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,880 | $63K |
| 71045 | Radiologic examination, chest; single view | <1% | 7,844 | $63K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,466 | $62K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 387 | $41K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,394 | $40K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,371 | $35K |
| 86850 | <1% | 1,219 | $35K | |
| 86780 | <1% | 1,886 | $35K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 3,496 | $34K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 6,224 | $33K |
| 36415 | Collection of venous blood by venipuncture | <1% | 55,071 | $32K |
| 84702 | <1% | 3,195 | $31K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 794 | $27K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,420 | $26K |
| 81001 | <1% | 12,887 | $20K | |
| 74018 | <1% | 362 | $19K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,602 | $18K |
| 87400 | <1% | 2,855 | $14K | |
| 86762 | <1% | 664 | $13K | |
| 83690 | <1% | 5,151 | $12K | |
| 76801 | <1% | 102 | $10K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 165 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,498 | $10K |
| 84484 | <1% | 3,841 | $10K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 83 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 767 | $9K |
| 87340 | <1% | 700 | $9K | |
| 80061 | Lipid panel | <1% | 3,159 | $9K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 520 | $8K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 579 | $8K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 703 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 234 | $7K |
| 87430 | <1% | 810 | $6K | |
| 86803 | <1% | 320 | $6K | |
| 83880 | <1% | 1,475 | $6K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 185 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,726 | $5K |
| 86900 | <1% | 1,891 | $5K | |
| 86901 | <1% | 1,898 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 26 | $4K |
| 87081 | <1% | 535 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 422 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 122 | $3K |
| 87420 | <1% | 504 | $3K | |
| J3490 | Unclassified drugs | <1% | 1,554 | $3K |
| 85027 | <1% | 568 | $3K | |
| 87077 | <1% | 2,044 | $3K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 337 | $3K |
| 76642 | <1% | 58 | $2K | |
| 82947 | <1% | 722 | $2K | |
| 81003 | <1% | 2,951 | $2K | |
| 81025 | <1% | 453 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,761 | $2K |
| 0002A | <1% | 94 | $2K | |
| 85610 | <1% | 3,871 | $2K | |
| 84439 | <1% | 1,050 | $2K | |
| 82951 | <1% | 121 | $2K | |
| 85730 | <1% | 2,143 | $2K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 18 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 750 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,192 | $2K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 12 | $2K |
| 86140 | <1% | 1,515 | $2K | |
| 87040 | <1% | 676 | $2K | |
| 82105 | <1% | 90 | $2K | |
| 83605 | <1% | 850 | $2K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 15 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,061 | $1K |
| 0001A | <1% | 104 | $1K | |
| 85651 | <1% | 1,040 | $1K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 406 | $1K |
| 93296 | <1% | 316 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,804 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 15 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,030 | $1K |
| 77080 | <1% | 319 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 317 | $1K |
| 86787 | <1% | 56 | $1K | |
| 72100 | <1% | 109 | $1K | |
| 93017 | <1% | 53 | $1K | |
| 82950 | <1% | 146 | $994.08 | |
| 96376 | <1% | 59 | $987.83 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 27 | $954.27 |
| 80047 | <1% | 738 | $934.02 | |
| 87147 | <1% | 364 | $931.97 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,122 | $780.60 |
| 82140 | <1% | 322 | $732.92 | |
| 84145 | <1% | 106 | $732.79 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 18 | $712.81 |
| 82607 | <1% | 681 | $705.63 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 18 | $606.23 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 18 | $606.23 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 18 | $606.23 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 750 | $586.23 |
| 82728 | <1% | 348 | $494.27 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 39 | $487.12 |
| 93280 | <1% | 43 | $453.29 | |
| 82077 | <1% | 146 | $416.08 | |
| 85014 | <1% | 1,357 | $411.07 | |
| 82746 | <1% | 416 | $392.49 | |
| 82150 | <1% | 93 | $370.02 | |
| 82565 | <1% | 1,021 | $345.59 | |
| 82570 | <1% | 743 | $343.99 | |
| 88342 | <1% | 14 | $338.54 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 44 | $288.62 |
| 93880 | <1% | 13 | $239.78 | |
| 82550 | <1% | 207 | $226.44 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 392 | $205.13 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 921 | $196.55 |
| 97161 | <1% | 12 | $191.97 | |
| 83550 | <1% | 245 | $188.61 | |
| 80051 | <1% | 290 | $175.94 | |
| 87186 | <1% | 154 | $171.45 | |
| 73560 | <1% | 18 | $167.05 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 354 | $166.98 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 376 | $159.20 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 134 | $151.13 |
| 87070 | <1% | 165 | $145.25 | |
| 87205 | <1% | 215 | $142.42 | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 53 | $132.54 |
| 84100 | <1% | 298 | $121.86 | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 52 | $121.80 |
| 83735 | <1% | 13 | $118.49 | |
| 83970 | <1% | 29 | $91.24 | |
| 82043 | <1% | 575 | $87.10 | |
| 84156 | <1% | 103 | $86.58 | |
| 93971 | <1% | 12 | $84.56 | |
| 82962 | <1% | 1,729 | $76.14 | |
| 80069 | <1% | 157 | $70.68 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $66.38 |
| 85007 | <1% | 17 | $57.00 | |
| 80164 | <1% | 230 | $56.85 | |
| 85378 | <1% | 26 | $46.64 | |
| 84520 | <1% | 297 | $36.90 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 358 | $31.02 |
| 80076 | <1% | 91 | $25.92 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,551 | $22.08 |
| 83540 | <1% | 30 | $19.98 | |
| 84436 | <1% | 40 | $19.62 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 20 | $16.23 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 13 | $12.29 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 901 | $12.17 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 15 | $10.07 |
| 94760 | <1% | 19 | $5.01 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,226 | $3.88 |
| 84703 | <1% | 13 | $2.98 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 856 | $1.82 |
| 36000 | <1% | 19 | $0.45 | |
| 99152 | 0% | 513 | $0.00 | |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 0% | 31 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 18 | $0.00 |
| 80299 | 0% | 14 | $0.00 | |
| J2704 | Injection, propofol, 10 mg | 0% | 1,088 | $0.00 |
| C1769 | Guide wire | 0% | 314 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 188 | $0.00 |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 0% | 14 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 85 | $0.00 |
| 84132 | 0% | 34 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWALKER, JEREMY (VICE PRESIDENT/CFO)
| Provider | Location | Paid |
|---|---|---|
| Hendrick Medical Center Brownwood | Brownwood, TX | $8.26M |
| Deluxe Dental Group Kuna | Kuna, ID | $1.37M |
| Jeremy L Walker Dental Corporation | Oceanside, CA | $3K |
| Hendrick Surgery Center LLC | Brownwood, TX | $324.00 |
| Hendrick Medical Center | Abilene, TX | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.